{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:17:07Z","timestamp":1761664627496},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,15]]},"DOI":"10.7759\/cureus.47065","type":"journal-article","created":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T15:30:57Z","timestamp":1697383857000},"source":"Crossref","is-referenced-by-count":1,"title":["The Study of Clinical Profile of Patients With Mucormycosis During COVID-19 Pandemic in Tertiary Care Hospital"],"prefix":"10.7759","author":[{"given":"Santosh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":".","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Dev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Kumar Nayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2020.07.014","article-title":"COVID-19 and comorbidities: deleterious impact on infected patients","volume":"13","author":"Ejaz H","year":"2020","unstructured":"Ejaz H, Alsrhani A, Zafar A, et al.. COVID-19 and comorbidities: deleterious impact on infected patients. J Infect Public Health. 2020, 13:1833-9. 10.1016\/j.jiph.2020.07.014","journal-title":"J Infect Public Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2021.100900","article-title":"Mucormycosis: a deadly black fungus infection among COVID-19 patients in India","volume":"12","author":"Choudhary NK","year":"2021","unstructured":"Choudhary NK, Jain AK, Soni R, Gahlot N. Mucormycosis: a deadly black fungus infection among COVID-19 patients in India. Clin Epidemiol Glob Health. 2021, 12:100900. 10.1016\/j.cegh.2021.100900","journal-title":"Clin Epidemiol Glob Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0030-6665(00)80010-9","article-title":"Mucormycosis of the nose and paranasal sinuses","volume":"33","author":"Ferguson BJ","year":"2000","unstructured":"Ferguson BJ. Mucormycosis of the nose and paranasal sinuses. OtolaryngolClin North Am. 2000, 33:349-65. 10.1016\/S0030-6665(00)80010-9","journal-title":"OtolaryngolClin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash H","year":"2019","unstructured":"Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi (Basel). 2019, 5:26. 10.3390\/jof5010026","journal-title":"J Fungi (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/13693780500464930","article-title":"The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus","volume":"44","author":"Chakrabarti A","year":"2006","unstructured":"Chakrabarti A, Das A, Mandal J, et al.. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006, 44:335-42. 10.1080\/13693780500464930","journal-title":"Med Mycol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.14740\/jmc3637","article-title":"Rhinocerebral mucormycosis and COVID-19 pneumonia","volume":"12","author":"Alekseyev K","year":"2021","unstructured":"Alekseyev K, Didenko L, Chaudhry B. Rhinocerebral mucormycosis and COVID-19 pneumonia. J Med Cases. 2021, 12:85-9. 10.14740\/jmc3637","journal-title":"J Med Cases"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.18869\/acadpub.cmm.2.4.15","article-title":"Clinical features, diagnosis, and outcomes of rhino-orbito-cerebral mucormycosis- a retrospective analysis","volume":"2","author":"Abdollahi A","year":"2016","unstructured":"Abdollahi A, Shokohi T, Amirrajab N, et al.. Clinical features, diagnosis, and outcomes of rhino-orbito-cerebral mucormycosis- a retrospective analysis. Curr Med Mycol. 2016, 2:15-23. 10.18869\/acadpub.cmm.2.4.15","journal-title":"Curr Med Mycol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2013.45.3.292","article-title":"Risk factors for mortality in patients with invasive mucormycosis","volume":"45","author":"Hong HL","year":"2013","unstructured":"Hong HL, Lee YM, Kim T, et al.. Risk factors for mortality in patients with invasive mucormycosis. Infect Chemother. 2013, 45:292-8. 10.3947\/ic.2013.45.3.292","journal-title":"Infect Chemother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive fungal diseases during COVID-19: we should be prepared","volume":"30","author":"Gangneux JP","year":"2020","unstructured":"Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR. Invasive fungal diseases during COVID-19: we should be prepared. J Mycol Med. 2020, 30:100971. 10.1016\/j.mycmed.2020.100971","journal-title":"J Mycol Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29219","article-title":"Clinical profile of patients admitted with mucormycosis during the COVID-19 pandemic in medicine emergency of a tertiary care hospital in north India","volume":"14","author":"Singla N","year":"2022","unstructured":"Singla N, Sharma N, Sharma N, Behera A, Bhatia M. Clinical profile of patients admitted with mucormycosis during the COVID-19 pandemic in medicine emergency of a tertiary care hospital in north India. Cureus. 2022, 14:e29219. 10.7759\/cureus.29219","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/iai.46.2.346-353.1984","article-title":"Estrogens inhibit mycelium-to-yeast transformation in the fungus Paracoccidioides brasiliensis: implications for resistance of females to paracoccidioidomycosis","volume":"46","author":"Restrepo A","year":"1984","unstructured":"Restrepo A, Salazar ME, Cano LE, Stover EP, Feldman D, Stevens DA. Estrogens inhibit mycelium-to-yeast transformation in the fungus Paracoccidioides brasiliensis: implications for resistance of females to paracoccidioidomycosis. Infect Immun. 1984, 46:346-53. 10.1128\/iai.46.2.346-353.1984","journal-title":"Infect Immun"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20213423","article-title":"Clinical profile and risk factors associated in patients of mucormycosis in COVID-19 pandemic: a study in a tertiary care center","volume":"9","author":"Anas M","year":"2021","unstructured":"Anas M, Choudhary RK, Alam N. Clinical profile and risk factors associated in patients of mucormycosis in COVID-19 pandemic: a study in a tertiary care center. J Res Med Sci. 2021, 9:2780-6. 10.18203\/2320-6012.ijrms20213423","journal-title":"J Res Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.17925\/ee.2023.19.2.2","article-title":"Clinical profile and factors associated with adverse outcomes in coronavirus disease 2019-associated mucormycosis: a single-centre study","volume":"19","author":"Nair KS","year":"2023","unstructured":"Nair KS, Alagesan M, Jose D, et al.. Clinical profile and factors associated with adverse outcomes in coronavirus disease 2019-associated mucormycosis: a single-centre study. Eur Endocrinol. 2023, 19:2. 10.17925\/ee.2023.19.2.2","journal-title":"Eur Endocrinol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.11.021","article-title":"A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India","volume":"26","author":"Patel A","year":"2020","unstructured":"Patel A, Kaur H, Xess I, et al.. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect. 2020, 26:944.e9-15. 10.1016\/j.cmi.2019.11.021","journal-title":"Clin Microbiol Infect"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-019-01774-z","article-title":"Rhino-orbital-cerebral mucormycosis: battle with the deadly enemy","volume":"72","author":"Gupta S","year":"2020","unstructured":"Gupta S, Goyal R, Kaore NM. Rhino-orbital-cerebral mucormycosis: battle with the deadly enemy. Indian J Otolaryngol Head Neck Surg. 2020, 72:104-11. 10.1007\/s12070-019-01774-z","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh AK","year":"2021","unstructured":"Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021, 15:102146. 10.1016\/j.dsx.2021.05.019","journal-title":"Diabetes Metab Syndr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_103_22","article-title":"Knowledge, attitude, and practice toward mucormycosis among patients presenting to six tertiary eye care hospitals in South India - a multicentric online questionnaire-based survey","volume":"70","author":"Jayagayathri R","year":"2022","unstructured":"Jayagayathri R, Mohanty P, Yadalla D, et al.. Knowledge, attitude, and practice toward mucormycosis among patients presenting to six tertiary eye care hospitals in South India - a multicentric online questionnaire-based survey. Indian J Ophthalmol. 2022, 70:2158-62. 10.4103\/ijo.IJO_103_22","journal-title":"Indian J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.15850\/ijihs.v11n1.3073","article-title":"Clinical profile of mucormycosis during the second wave of COVID-19 in a tertiary care center in India","volume":"11","author":"Kunhiparambath SK","year":"2023","unstructured":"Kunhiparambath SK, Oommen B, Keeriyatt Govindan SK, Nair KS, Madayambath S. Clinical profile of mucormycosis during the second wave of COVID-19 in a tertiary care center in India. Int J Integr Health Sci. 2023, 11:20-6. 10.15850\/ijihs.v11n1.3073","journal-title":"Int J Integr Health Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), report 1","volume":"69","author":"Sen M","year":"2021","unstructured":"Sen M, Honavar SG, Bansal R, et al.. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), report 1. Indian J Ophthalmol. 2021, 69:1670-92. 10.4103\/ijo.IJO_1565_21","journal-title":"Indian J Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2021.5201","article-title":"Cumulative mortality and factors associated with outcomes of mucormycosis after COVID-19 at a multispecialty tertiary care center in India","volume":"140","author":"Choksi T","year":"2022","unstructured":"Choksi T, Agrawal A, Date P, et al.. Cumulative mortality and factors associated with outcomes of mucormycosis after COVID-19 at a multispecialty tertiary care center in India. JAMA Ophthalmol. 2022, 140:66-72. 10.1001\/jamaophthalmol.2021.5201","journal-title":"JAMA Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9030523","article-title":"Epidemiology of mucormycosis in India","volume":"9","author":"Prakash H","year":"2021","unstructured":"Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms. 2021, 9:523. 10.3390\/microorganisms9030523","journal-title":"Microorganisms"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-022-01891-y","article-title":"COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome","volume":"51","author":"Sahu M","year":"2023","unstructured":"Sahu M, Shah M, Mallela VR, et al.. COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome. Infection. 2023, 51:407-16. 10.1007\/s15010-022-01891-y","journal-title":"Infection"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s43163-023-00430-2","article-title":"Clinical profile of COVID-19-associated mucormycosis patients and the clinical suspects: a descriptive audit","volume":"39","author":"Amalanathan S","year":"2023","unstructured":"Amalanathan S, Satish Kumar C, Abinaya R, et al.. Clinical profile of COVID-19-associated mucormycosis patients and the clinical suspects: a descriptive audit. 2023, 39:73. 10.1186\/s43163-023-00430-2"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/191077-the-study-of-clinical-profile-of-patients-with-mucormycosis-during-covid-19-pandemic-in-tertiary-care-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:35Z","timestamp":1707509135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/191077-the-study-of-clinical-profile-of-patients-with-mucormycosis-during-covid-19-pandemic-in-tertiary-care-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,15]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.47065","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,15]]}}}